Twinning induction of single-bearing Noemi ewes is an important avenue to maximize the economic feasibility of sheep production. Sixty Noemi ewes were used and randomly assigned to six treatment groups (n=10/group).Two sources of FSH [i.e., porcine (P) vs. human (H)] were given as a single dose or in six doses. The control 1 group was given a single dose of saline (C1), while the control 2 group was given six doses of saline (C6). Ewes in group 3 (P1) were given a single dose of p-FSH, in group 4 six doses of p-FSH (P6), in group 5 a single dose of h-FSH (H1), and in group 6 six doses of h-FSH (H6). The ewes were inserted with CIDR for 10 days with FSH given on day 8. A fertile ram was used at the onset of estrus. Blood samples were collected for hormone analyses. The time between CIDR removal and onset of estrus (63, 38 and 26 hrs. in C, P, and H, respectively) was shortened by FSH administration. FSH increased the incidence of twinning, however single dose resulted in more stillbirths and mortalities. The neonatal survival rate decreased in the P1 (40%) compared to the P6 (65%) treatments. Both sources of FSH raised progesterone and estradiol 17-β compared to the controls. Contrariwise, both h- and p-FSH reduced T4; however, h-but not p-FSH raised T3. In conclusion, using rh-FSH at six descending doses of a total 180 IU in Noemi ewes produced two viable neonates. Moreover, the exogenous FSH raised the sex hormones and T3 in the ewes.

Aim: The aim of this study was to investigate the effectiveness of using recombinant human follicle-stimulating hormone (FSH) compared with pituitary-derived porcine FSH given as one dose or multiple doses on the neonatal traits, follicular dynamics, and maternal blood biochemical constituents in Noemi ewes. Materials and Methods: A 3×2 factorial arrangement was designed utilizing 60 adults Noemi ewes to test the effects of using two sources of FSH (human vs. porcine) in addition to control, either given as a single total dose or six descending doses to provoke twinning. Six treatments (T) were tested (n=10 ewes/T). C1 and C6 served as control ewes given saline as one dose and six doses, respectively; H1 and H6 ewes were given human FSH as one and six doses; and P1 and P6 ewes were given porcine FSH similar to the above treatments. Saline and/or FSH administration were administered at days 8, 9, and 10 of the 10-day controlled internal drug release (CIDR) implant. At CIDR removal, fertile rams were used for natural mating. Blood samples for the assessment of serum metabolites were collected. Results: Twinning increased in FSH-treated ewes than control. However, giving FSH of either source as a single dose resulted in a higher incidence of stillbirths. Pregnancy rates were 30, 40, 50, 60, 70, and 80% in C1, C6, P1, P6, H1, and H6, respectively. Respective percent of ewes delivering twins/multiple birth was 0, 0, 80, 66.7, 71.4, and 87.5%. FSH of human source was more efficient for folliculogenesis than porcine FSH. Administration of FSH increased blood cholesterol, decreased high-density lipoprotein; however, low-density lipoprotein levels were not different than control. Moreover, an interaction (p<0.05) exists between source and type of FSH administration on blood glucose. Six doses of FSH elevated blood protein. Blood albumin decreased by porcine-FSH but not affected by human-FSH. Blood globulins were not different due to source of FSH, whereas giving FSH as six doses increased globulins than in single-dose protocol. Contrariwise, an interaction was found between source and type of FSH administration on elevating the activity of alanine aminotransferase and reducing the activity of aspartate aminotransferase. Conclusion: Administration of human FSH at 180 IU in six descending doses resulted in the best neonatal outcomes and maternal health in Noemi ewes.